StockWatch
·

Cyient DLM Ltd

BSE: 543933

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
283.20
-1.9%+34.5%
Expenditure
260.91
+1.5%+33.6%
Net Profit
16.70
-29.3%+48.1%
OPM %
11.81%
-1.44pp-0.35pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00111.03222.07333.10444.14Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Record Order Book, But Sequential Profit Collapsed — Execution Questions Persist

order-book · sequential-momentum · margin-expansion

Result verdictFollow-upQ1 FY2724 Jul 20266 minIndustrials & Infra

Record order book & strong growth, but sequential momentum halts

record order book · margin expansion · aerospace moat

TranscriptDeep diveQ1 FY2724 Jul 20266 minIndustrials & Infra

Cyient DLM Q1: consolidated PAT more than doubles YoY to ₹16.3 Cr, revenue up 34%

Industrials · earnings · quarterly results

ResultsQ1 FY2721 Jul 20263 minIndustrials & Infra
Latest
Quarterly Result21 Jul, 5:00 pm

Cyient DLM Q1: consolidated PAT more than doubles YoY to ₹16.3 Cr on 34% revenue jump

Cyient DLM opened FY27 with a decisive return to growth: consolidated revenue rose 34.3% YoY to ₹373.8 Cr (from ₹278.4 Cr) and net profit more than doubled to ₹16.3 Cr (+118% YoY vs ₹7.5 Cr), reversing the ~17% revenue decline the company posted in FY26. Net margin widened to 4.4% from 2.6% a year ago and EBITDA margin held in double digits at ~10.5% (FY26: 10.3%), so the profit surge is operating leverage, not other income — reported other income was near-nil at ₹0.3 Cr versus ₹4.2 Cr in the year-ago quarter, meaning the bottom line grew despite a weaker non-operating line. This is a genuinely strong, YoY-clean print (no exceptional items either side of the comparison). Sequentially the picture is flatter and needs a caveat: revenue edged up just 1.3% QoQ and PAT fell 27% from Q4's ₹22.4 Cr, but Q4 carried a ~₹5.1 Cr one-off other-income gain (earnout liability fair-valuation) that inflated its base — strip that and the sequential operating trend is broadly stable rather than deteriorating. On expectations, there is no published Q1-specific street consensus; against management's own last-call guidance the quarter is on track — the promised 'return to growth' has arrived and the commitment to sustain double-digit EBITDA margins was met. The result lands alongside the board confirming Dr. Ganesh Natarajan to the board of US subsidiary Cyient DLM Inc and follows a quarter of leadership additions (Ramakanth Alapati as President & CSO), consistent with the stated push into automotive and AI-infrastructure and higher-value build-to-spec work. The swing factor into H2 remains execution of the record ₹2,416.6 Cr order book (1.5x book-to-bill), which underwrites the FY27 growth thesis but has yet to translate into margin expansion beyond the double-digit floor.

21 Jul 2026, 05:00 pm

Corporate Events

Board MeetingCYIENTDLM
2026
15Oct

Board Meeting

The Board of Directors will consider and approve the Un-Audi…

BSE Filing ↗
Board MeetingCYIENTDLM
2026
21Jul

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingCYIENTDLM
2026
21Apr

Board Meeting

To consider and approve the audited financial results for th…

BSE Filing ↗
Board MeetingCYIENTDLM
2024
21Oct

Board Meeting

Consider and approve the un-audited financial results

BSE Filing ↗